Duke University Medical Center has been engaged in the training of clinicians and scientists in the area of cardiovascular diseases for over 50 years. The philosophy has been to integrate training and research by creating an environment that facilitates the natural linkages among programs and departments throughout the University. By any measure, the program has succeeded in training several generations of outstanding investigators who are now prominent teachers and leaders in academic medicine. Much of this success can be attributed to 39 years of funding of the Cardiovascular Training Program Grant. Our goal is to maintain this history of productivity by creating an environment that will ensure that Duke will continue to contribute to the development of young investigators capable of pursuing successful research careers in cardiovascular fields. Since the last competing renewal, a new Director and Co-Director have assumed leadership. In collaboration with the former Director, the team has implemented a number of substantial enhancements to the educational and research experience of our trainees. Some examples include: 1) a new mentoring program in which all trainees meet semiannually with senior faculty who advise them on their research program and on career pathways, in the manner of a thesis committee; 2) a new External Advisory Committee; 3) close integration between the Training Program and the Duke Cardiovascular Research Center (CVRC); 4) a new required Molecular Cardiovascular Biology course; 5) semiannual Individual Development Plans (IDPs) completed by Fellows. These major enhancements were implemented in the context of continued improvements in critical components that have made our training program successful, such as: 1) didactic course work during research fellowship that can lead to a Masters Degree from the School of Medicine; 2) weekly summer seminars devoted to mentoring and to writing grant applications; 3) semiannual written evaluations of (a) Mentors by Fellows and (b) Fellows by Mentors; 4) an annual CVRC Research Symposium, with awards for the best Fellow presentation; and 5) a biweekly CVRC basic science seminar series, featuring outstanding external and Duke cardiovascular faculty (drawn from multiple Schools, Departments, and Institutes, and Centers). The goal of this program is to continue training talented physician-scientists and to build on the Duke environment that will ensure our Fellows develop into highly successful, innovative, independent cardiovascular investigators.

Public Health Relevance

Statement The training of future academic scientists in cardiovascular research recognizes the need to accelerate translation of findings from discovery sciences into clinically useful therapies and strategies. This training program will provide a high-quality mentored research training experience for those future researchers who collectively will make the discoveries of scientists working in basic laboratories available to patients in the form of improved medical care.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
3T32HL007101-41S1
Application #
9391838
Study Section
Program Officer
Wang, Wayne C
Project Start
1975-07-01
Project End
2021-03-31
Budget Start
2016-12-01
Budget End
2017-03-31
Support Year
41
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Fudim, Marat; Jones, W Schuyler; Boortz-Marx, Richard L et al. (2018) Splanchnic Nerve Block for Acute Heart Failure. Circulation 138:951-953
Mokalled, Mayssa H; Poss, Kenneth D (2018) A Regeneration Toolkit. Dev Cell 47:267-280
Wang, Yingxue; Christopher, Bridgette A; Wilson, Kirkland A et al. (2018) Propionate-induced changes in cardiac metabolism, notably CoA trapping, are not altered by l-carnitine. Am J Physiol Endocrinol Metab 315:E622-E633
Fudim, Marat; Mentz, Robert J (2018) Early versus late readmission during the vulnerable phase following hospitalization for heart failure: reply. Eur J Heart Fail 20:1166
Bu, Pengcheng; Chen, Kai-Yuan; Xiang, Kun et al. (2018) Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis. Cell Metab 27:1249-1262.e4
Ahn, Seungkirl; Pani, Biswaranjan; Kahsai, Alem W et al. (2018) Small-Molecule Positive Allosteric Modulators of the ?2-Adrenoceptor Isolated from DNA-Encoded Libraries. Mol Pharmacol 94:850-861
McGarrah, Robert W; Crown, Scott B; Zhang, Guo-Fang et al. (2018) Cardiovascular Metabolomics. Circ Res 122:1238-1258
Fudim, Marat; Liu, Peter R; Shrader, Peter et al. (2018) Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry. J Am Heart Assoc 7:
Kleiner Shochat, Michael; Fudim, Marat; Shotan, Avraham et al. (2018) Prediction of readmissions and mortality in patients with heart failure: lessons from the IMPEDANCE-HF extended trial. ESC Heart Fail 5:788-799
Fudim, Marat; O'Connor, Christopher M; Mulder, Hillary et al. (2018) Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION. Am Heart J 205:133-141

Showing the most recent 10 out of 248 publications